Skip to main content

Advertisement

Table 3 Impact of LDL cholesterol, triglycerides, HDL cholesterol, and adiponectin on the level of MDA-LDL in the multivariate analyses

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

  Model 1 Model 2
  β p β p
LDL cholesterol 0.452 <0.0001 0.444 <0.0001
Triglycerides* 0.317 <0.0001 0.318 <0.0001
HDL cholesterol −0.137 0.049 −0.139 0.048
Adiponectin* −0.049 0.481 −0.032 0.648
  1. Abbreviations: HDL high-density lipoprotein, LDL low-density lipoprotein, MDA-LDL malondialdehyde-modified LDL.
  2. In model 1 (R2 = 0.361), LDL cholesterol, triglycerides, HDL cholesterol, and adiponectin were included as the variables in the multiple regression analysis. In model 2 (R2 = 0.365), medications (metformin and α-glucosidase inhibitors) were added to the variables for the model 1 analysis.
  3. *Log-transformed values were subjected to statistical analyses.